Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Digital Storytelling empowers and liberates students
2014-10-17

In January 2014, Jode Brexa, an American Fulbright scholar, came to our university and moved into the guest room at Welwitschia residence.

It so happened that Brexa and Elize Rall, residence head of Welwitschia – better known as Wel-Wel – started talking about digital storytelling. Brexa’s Digital Storytelling project captured Rall’s imagination. Shortly thereafter, Brexa convinced the RC members of Wel-Wel to participate in the project.

Digital storytelling is, on the most basic level, the use of computer-based resources to tell stories. The idea is to combine the art of storytelling with multimedia – including graphics, photos, text, audio, image and/or music.

The Wel-Wel students were taught storytelling skills and each student’s unique story was recorded and edited. It was so successful that they then showed their stories to the Rector and Dean of Students. Brexa will now – with their permission – take their stories to America with her, where she will share it with her community.

During the weekend of 10–12 October 2014, the RC of Wel-Wel introduced 12 learners, who are currently in Grade 10 at the Christiaan Liphoko School, to the project. The learners stayed in the gazellie for the weekend and, in the course of a few days, learned how much power is locked up in their personal stories. They learned that everyone’s story has the power to inspire and empower.

Wel-Wel has been involved in various outreach projects to the community. However, this was the first time that Wel-Wel literally brought the community to their doorstep. This is also not a charitable project. It is uplifted students reaching out to the youth to empower them in order to empower others in turn.

Meanwhile, Brexa also linked the project to the university’s Schools Partnership Project. The programme works through mentorship programmes to uplift previously disadvantaged schools. Hands were also taken with Columba Leadership NGO – financed by Old Mutual.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept